SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63

Molecular and Cellular Biology

Volumn 31, Issue 8, 2011, Pages 1679-1689

  Bornstein, Chamutal ^a   Brosh, Ran ^a   Molchadsky, Alina ^a   Madar, Shalom ^a   Kogan Sakin, Ira ^a   Goldstein, Ido ^a   Chakravarti, Deepavali ^b   Flores, Elsa R ^b   Goldfinger, Naomi ^a   Sarig, Rachel ^a   Rotter, Varda ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P63; SPATA18 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DNA STRUCTURE; EMBRYO; EMBRYO CELL; FIBROBLAST; GENE IDENTIFICATION; GENE INDUCTION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRON; MALE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SEMINIFEROUS TUBULE; SPERMATID; SPERMATOCYTE; SPERMATOGENESIS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE; HUMANS; MALE; MICE; PHOSPHOPROTEINS; PROTEINS; RNA INTERFERENCE; SPERMATOGENESIS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79953135000     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01072-10     Document Type: Article

References (65)

1. Almon, E., et al. 1993. Testicular tissue-specific expression of the p53 suppressor gene. Dev. Biol. 156:107-116.
2. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
3. Barbieri, C. E., L. J. Tang, K. A. Brown, and J. A. Pietenpol. 2006. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res. 66:7589-7597.
4. Beumer, T. L., H. L. Roepers-Gajadien, L. S. Gademan, D. H. Rutgers, and D. G. de Rooij. 1997. P21(Cip1/WAF1) expression in the mouse testis before and after X irradiation. Mol. Reprod Dev. 47:240-247.
5. Blanco-Rodriguez, J., and C. Martinez-Garcia. 1999. Apoptosis is physiologically restricted to a specialized cytoplasmic compartment in rat spermatids. Biol. Reprod. 61:1541-1547.
6. Brandt, T., M. Petrovich, A. C. Joerger, and D. B. Veprintsev. 2009. Conservation of DNA-binding specificity and oligomerisation properties within the p53 family. BMC Genomics 10:628.
7. Brosh, R., and V. Rotter. 2010. Transcriptional control of the proliferation cluster by the tumor suppressor p53. Mol. Biosyst. 6:17-29.
8. Brosh, R., and V. Rotter. 2009. When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9:701-713.
9. Brosh, R., et al. 2010. p53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss. FEBS Lett. 584: 2473-2477.
10. Choi, J., et al. 2002. Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. Mol. Cell. Biol. 22:1094-1105.
11. Reference deleted
12. Donehower, L. A., et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
13. el-Deiry, W. S., et al. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
14. Flores, E. R., et al. 2005. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7:363-373.
15. Green, D. R., and G. Kroemer. 2009. Cytoplasmic functions of the tumour suppressor p53. Nature 458:1127-1130.
16. Guo, X., et al. 2009. TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat. Cell Biol. 11:1451-1457.
17. Hamer, G., I. S. Gademan, H. B. Kal, and D. G. de Rooij. 2001. Role for c-Abl and p73 in the radiation response of male germ cells. Oncogene 20:4298-4304.
18. Harms, K., S. Nozell, and X. Chen. 2004. The common and distinct target genes of the p53 family transcription factors. Cell. Mol. Life Sci. 61:822-842.
19. Harvey, M., M. J. McArthur, C. A. Montgomery, Jr., A. Bradley, and L. A. Donehower. 1993. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 7:938-943.
20. Hasegawa, M., Y. Zhang, H. Niibe, N. H. Terry, and M. L. Meistrich. 1998. Resistance of differentiating spermatogonia to radiation-induced apoptosis and loss in p53-deficient mice. Radiat. Res. 149:263-270.
21. Hendry, J. H., A. Adeeko, C. S. Potten, and I. D. Morris. 1996. P53 deficiency produces fewer regenerating spermatogenic tubules after irradiation. Int. J. Radiat. Biol. 70:677-682.
22. Hess, R. A., and L. Renato de Franca. 2008. Spermatogenesis and cycle of the seminiferous epithelium. Adv. Exp. Med. Biol. 636:1-15.
23. Hilscher, W., and B. Hilscher. 1976. Kinetics of the male gametogenesis. Andrologia 8:105-116.
24. Hu, W. 2009. The role of p53 gene family in reproduction. Cold Spring Harb. Perspect. Biol. 1:a001073.
25. Hu, W., Z. Feng, A. K. Teresky, and A. J. Levine. 2007. p53 regulates maternal reproduction through LIF. Nature 450:721-724.
26. Iida, H., Y. Honda, T. Matsuyama, Y. Shibata, and T. Inai. 2006. Spetex-1: a new component in the middle piece of flagellum in rodent spermatozoa. Mol. Reprod. Dev. 73:342-349.
27. Iida, H., J. Ichinose, T. Kaneko, T. Mori, and Y. Shibata. 2004. Complementary DNA cloning of rat spetex-1, a spermatid-expressing gene-1, encoding a 63 kDa cytoplasmic protein of elongate spermatids. Mol. Reprod. Dev. 68:385-393.
28. Jacobs, W. B., D. R. Kaplan, and F. D. Miller. 2006. The p53 family in nervous system development and disease. J. Neurochem. 97:1571-1584.
29. Kalo, E., et al. 2007. Mutant p53 attenuates the SMAD-dependent transforming growth factor (1 (TGF-(1) signaling pathway by repressing the expression of TGF-( receptor type II. Mol. Cell. Biol. 27:8228-8242.
30. Kaneko, T., E. Murayama, H. Kurio, A. Yamaguchi, and H. Iida. 2010. Characterization of Spetex-1, a new component of satellite fibrils associated with outer dense fibers in the middle piece of rodent sperm flagella. Mol. Reprod. Dev. 77:363-372.
31. Kluin, P. M., and D. G. de Rooij. 1981. A comparison between the morphology and cell kinetics of gonocytes and adult type undifferentiated spermatogonia in the mouse. Int. J. Androl. 4:475-493.
32. Kurita, T., A. A. Mills, and G. R. Cunha. 2004. Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis. Development 131:1639-1649.
33. Lane, D. P. 1992. Cancer p53, guardian of the genome. Nature 358:15-16.
34. Leblond, C. P., and Y. Clermont. 1952. Spermiogenesis of rat, mouse, hamster and guinea pig as revealed by the periodic acid-fuchsin sulfurous acid technique. Am. J. Anat. 90:167-215.
35. Levine, A. J., and M. Oren. 2009. The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer. 9:749-758.
36. Li, N., et al. 2006. TA-p63-( regulates expression of (N-p63 in a manner that is sensitive to p53. Oncogene 25:2349-2359.
37. Malkov, M., Y. Fisher, and J. Don. 1998. Developmental schedule of the postnatal rat testis determined by flow cytometry. biology of reproduction. 59:84-92.
38. Menendez, D., A. Inga, and M. A. Resnick. 2009. The expanding universe of p53 targets. Nat. Rev. Cancer. 9:724-737.
39. Mills, A. A., et al. 1999. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713.
40. Milyavsky, M., et al. 2003. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res. 63:7147- 7157.
41. Milyavsky, M., et al. 2005. Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation. Cancer Res. 65:4530-4543.
42. Molchadsky, A., N. Rivlin, R. Brosh, V. Rotter, and R. Sarig. 2010. p53 is balancing development, differentiation and de-differentiation to assure cancer suppression. Carcinogenesis 31:1501-1508.
43. Moll, U. M., and N. Slade. 2004. p63 and p73: roles in development and tumor formation. Mol. Cancer Res. 2:371-386.
44. Namekawa, S. H., et al. 2006. Postmeiotic sex chromatin in the male germline of mice. Curr. Biol. 16:660-667.
45. Nicol, C. J., M. L. Harrison, R. R. Laposa, I. L. Gimelshtein, and P. G. Wells. 1995. A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat. Genet. 10:181-187.
46. Ossovskaya, V. S., et al. 1996. Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc. Natl. Acad. Sci. U. S. A. 93:10309-10314.
47. Petre-Lazar, B., et al. 2007. The role of p63 in germ cell apoptosis in the developing testis. J. Cell. Physiol. 210:87-98.
48. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-4884.
49. Rhodes, D. R., et al. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6:1-6.
50. Richardson, A. L., et al. 2006. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9:121-132.
51. Rotter, V., et al. 1994. Does wild-type p53 play a role in normal cell differentiation? Semin. Cancer Biol. 5:229-236.
52. Rotter, V., et al. 1993. Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc. Natl. Acad. Sci. U. S. A. 90:9075-9079.
53. Russell, L. D. 1979. Spermatid-Sertoli tubulobulbar complexes as devices for elimination of cytoplasm from the head region late spermatids of the rat. Anat. Rec. 194:233-246.
54. Sarig, R., et al. 2010. Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. J. Exp. Med. 207:2127-2140.
55. Schwartz, D., N. Goldfinger, and V. Rotter. 1993. Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene 8:1487-1494.
56. Stiewe, T. 2007. The p53 family in differentiation and tumorigenesis. Nat. Rev. Cancer. 7:165-168.
57. Suad, O., et al. 2009. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations. J. Mol. Biol. 385:249-265.
58. Suliman, Y., et al. 2001. p63 expression is associated with p53 loss in oralesophageal epithelia of p53-deficient mice. Cancer Res. 61:6467-6473.
59. Suzuki-Toyota, F., K. Ishibashi, and S. Yuasa. 1999. Immunohistochemical localization of a water channel, aquaporin 7 (AQP7), in the rat testis. Cell Tissue Res. 295:279-285.
60. Vassilev, L. T., et al. 2004. In vivo activation of the p53 pathway by smallmolecule antagonists of MDM2. Science 303:844-848.
61. Vousden, K. H., and K. M. Ryan. 2009. p53 and metabolism. Nat. Rev. Cancer. 9:691-700.
62. Wei, C. L., et al. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219.
63. Yang, A., et al. 1999. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-718.
64. Yang, A., et al. 2000. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404:99-103.
65. Yao, J. Y., and J. K. Chen. 2010. TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress. Biochem. Biophys. Res. Commun. 403:310-315.